This activity includes patient counseling video vignettes and a Pharmacist All-Star Challenge posttest.
Program Description
Bipolar I disorder, characterized by recurrent episodes of depression and mania, is the leading cause of disability in young adults. Patients who have bipolar disorder struggle with management of comorbid conditions and reduced quality of life as well as stigma related to their diagnosis. Achievement of successful treatment outcomes is multifaceted and requires close coordination between the provider, patient, and/or caregivers to develop a treatment plan that meets the patient’s needs. Pharmacists have an important role in empowering patients by identifying symptoms that warrant additional care, counseling on treatment expectations, and monitoring effects of therapy. This activity will provide pharmacists with an overview on the current state of management of bipolar I disorder and an update on the role of new therapies. Patient case vignettes and an interactive posttest will enable pharmacists to practice applying key concepts and counseling when providing treatment and management plans for patients with bipolar I disorder.
Target audience: Health-system pharmacists, retail pharmacists, specialty pharmacists
Type of activity: Application
Release date: January 31, 2022
Expiration date: March 15, 2023
Time to complete activity: 2.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the types of bipolar disorder, pathophysiology, and prevalence as well as symptomology of patients
- Analyze evidence-based treatment for bipolar I disorder including efficacy, safety profiles, and treatment considerations for the use of newly approved and emerging treatment options
- Examine the role of pharmacists in counseling, monitoring, and providing education to help manage patients with bipolar I disorder
Megan Maroney, PharmD, BCPP
Clinical Associate Professor
Ernest Mario School of Pharmacy
Rutgers, the State University of New Jersey
Piscataway, New Jersey
Kelsey Giara, PharmD (Medical Writer)
Freelance Medical Writer
Pelham, New Hampshire
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.5 contact hours (0.25 CEU) under the ACPE universal activity number 0290-0000-22-006-H01-P. The activity is available for CE credit through March 15, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
Megan Maroney, PharmD, BCPP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Novus Medical Education, Sunovion Pharmaceuticals
Speakers Bureau: Otsuka Pharmaceuticals
Other: honoraria received from American College of Clinical Pharmacy, College of Psychiatric and Neurologic Pharmacists, Society of Psychiatric Advanced Practice Nurses, New Jersey Society of Health-System Pharmacists
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Buszka, PharmD, BCPS; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no financial relationships with commercial interests to disclose.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms